AEON Biopharma, Inc. (AEON)
AEON Biopharma was planning to go public, but the IPO has been withdrawn.
Stock Price: $14.00 - $16.00
Current IPO price range
Total Valuation
AEON Biopharma has a market cap or net worth of $329.94 million. The enterprise value is $398.68 million.
| Market Cap | 329.94M |
| Enterprise Value | 398.68M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
AEON Biopharma has 22.00 million shares outstanding.
| Shares Outstanding | 22.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 292.76 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 353.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of n/a, with a Debt / Equity ratio of n/a.
| Current Ratio | n/a |
| Quick Ratio | 1.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $187,833 |
| Profits Per Employee | -$8.90M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| Total Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Average Volume (30 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AEON Biopharma had revenue of $1.13 million and -53.41 million in losses. Earnings per share was -$2.43.
| Revenue | 1.13M |
| Gross Profit | 1.13M |
| Operating Income | -54.47M |
| Net Income | -53.41M |
| EBITDA | -53.41M |
| EBIT | -53.41M |
| Earnings Per Share (EPS) | -$2.43 |
Balance Sheet
The company has $10.61 million in cash and $79.34 million in debt, giving a net cash position of -$68.74 million or -$3.12 per share.
| Cash & Cash Equivalents | 10.61M |
| Total Debt | 79.34M |
| Net Cash | -68.74M |
| Net Cash Per Share | -$3.12 |
| Book Value | -207.66M |
| Book Value Per Share | -9.44 |
| Working Capital | 8.62M |
Cash Flow
| Operating Cash Flow | -19.96M |
| Capital Expenditures | n/a |
| Free Cash Flow | -19.96M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -4,833.01% and -4,738.86%.
| Gross Margin | 100.00% |
| Operating Margin | -4,833.01% |
| Pretax Margin | n/a |
| Profit Margin | -4,738.86% |
| EBITDA Margin | -4,738.78% |
| EBIT Margin | -4,738.78% |
| FCF Margin | -1,770.81% |
Dividends & Yields
AEON Biopharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -16.19% |
| FCF Yield | -6.05% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |